Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Cancer Causes Control. 2019 Feb 20;30(4):355–363. doi: 10.1007/s10552-019-01139-5

Table 3.

Association of metabolic factors according to NCEP criteria with endometrial cancer, Women’s Health Initiative

Variable Cases
N
Non-cases
N
HRa 95% CI
Metabolic syndrome (including WC)
 No. of components
  0 15 1,961 1.00 Ref.
  1 27 3,036 1.18 0.62–2.21
  2 35 2,961 1.65 0.90–3.04
  3 44 2,554 2.51 1.39–4.56
  4 34 1,626 3.16 1.70–5.86
  5 21 747 4.31 2.99–8.49
  P for trend < 0.001
Metabolic syndrome (excluding WC)b
 No. of components
  0 26 2,523 1.00 Ref.
  1 43 4,023 0.88 0.54–1.45
  2 47 3,310 1.09 0.66–1.80
  3 34 2,107 1.16 0.68–1.98
  4 26 922 1.94 1.09–3.46
  P for trend 0.017

WC waist circumference

a

Adjusted for age, pack-years of smoking, alcohol intake, physical activity, hormone therapy ever, oral contraceptive ever, menopausal status, education, ethnicity, family history of endometrial cancer and allocation to the observational study or intervention/placebo/control arm of each clinical trial

b

Also adjusted for WC